|
ZNF608 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.253800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.410000E-02 |
| Normal-vs-Stage2 |
5.793600E-01 |
| Normal-vs-Stage3 |
8.827700E-02 |
| Normal-vs-Stage4 |
1.848770E-01 |
| Stage1-vs-Stage2 |
2.863400E-01 |
| Stage1-vs-Stage3 |
7.237400E-01 |
| Stage1-vs-Stage4 |
4.805000E-01 |
| Stage2-vs-Stage3 |
4.751200E-01 |
| Stage2-vs-Stage4 |
6.506200E-01 |
| Stage3-vs-Stage4 |
7.510400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.745600E-02 |
| Normal-vs-AfricanAmerican |
5.164000E-04 |
| Normal-vs-Asian |
2.147600E-02 |
| Caucasian-vs-AfricanAmerican |
1.409800E-02 |
| Caucasian-vs-Asian |
3.316600E-01 |
| AfricanAmerican-vs-Asian |
1.246810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.043980E-01 |
| Normal-vs-Female |
3.374100E-02 |
| Male-vs-Female |
8.397200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.781900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.820300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.356400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.959600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.948200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.885400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.030400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.880000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.922800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.341000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.944190E-02 |
| Classical-VS-Follicular |
1.161110E-03 |
| Classical-VS-Other |
1.673650E-01 |
| Classical-VS-Normal |
9.464200E-03 |
| Tall-VS-Follicular |
2.718600E-01 |
| Tall-VS-Other |
1.680400E-01 |
| Tall-VS-Normal |
3.269200E-01 |
| Follicular-VS-Other |
3.099800E-02 |
| Follicular-VS-Normal |
9.132000E-01 |
| Other-VS-Normal |
1.132360E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.420970E-01 |
| Normal-vs-N1 |
1.238840E-01 |
| N0-vs-N1 |
7.852400E-01 |
|
|
